Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05773495 · ClinicalTrials.gov registry record · NA

Implementation of Teleophthalmology in Urban Health Systems Study

A NA study of Diabetic Retinopathy, sponsored by University of Wisconsin, Madison.

Active
Registry status
NA
Development phase
12,840
Enrollment target
1
Study location

NCT05773495 is a NA study of Diabetic Retinopathy that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 12,840 participants, above the 1,451-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (785% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05773495, a NA study of Diabetic Retinopathy, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
12,840 participants
Enrollment target
1
Study location

Study Summary

This study is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in urban, multi-payer health systems.

Conditions Studied

Interventions

  • OTHER I-SITE Intervention
  • OTHER Usual Care Teleophthalmology

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 12,840 participants
Start Date 2024-03-19
Est. Completion 2028-12-31
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05773495

The ClinicalTrials.gov registry entry for NCT05773495 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 12,840 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,451-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (785% higher). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 2 interventions - of which I-SITE Intervention is the first listed.

NCT05773495 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05773495 about?

NCT05773495 is a clinical study titled "Implementation of Teleophthalmology in Urban Health Systems Study". This study is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in urban, multi-payer health systems.

What is the current status of trial NCT05773495?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 12,840 participants. The study started on 2024-03-19. Estimated completion is 2028-12-31.

What conditions does trial NCT05773495 study?

This clinical trial studies the following conditions: Diabetic Retinopathy.

What interventions are being tested in trial NCT05773495?

The interventions under investigation include: I-SITE Intervention (OTHER), Usual Care Teleophthalmology (OTHER).

Who is sponsoring clinical trial NCT05773495?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05773495 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Retinopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.